Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Hematology
Disease Category: Sickle Cell Disease

Trial Information

A Prospective, Non-Interventional, Multi-Center, Open Label Study to Evaluate the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Subjects with Severe Hemophilia A Receiving Prophylaxix and On Demand Treatment Regimens

You have/your son has been asked to participate in this research study because you/your son have severe hemophilia A. You are/your son is between the ages of 16 and 25 years old and have been receiving rFVIII for treatment of your/your son’s bleeds. The purpose of this study is to understand how often bleeding events occur in subjects who voluntarily decide to switch from prophylaxis to on-demand treatment and in those subjects who remain on prophylaxis. In addition, this study will look into the effect of switching treatment on quality of life, development of target joints (repeated bleeding episodes in the same joint), activity level as well as the reasons that might influence the desire to switch. Your/your son's participation in this study is expected to last about 18 months.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

City of Hope
1500 East Duarte Road
Duarte, CA 91010-3000
Phone: 866-896-HOPE (4673)

View Google Map

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.